Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Morabito

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Annals of the New York Academy of Sciences|January 31, 2007
Hormonal treatment of human hepatocellular carcinomaMassimo Di Maio, Ermelinda De Maio, Alessandro Morabito, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Endocrine-Related Cancer|June 16, 2009
Target-based therapies in breast cancer: current status and future perspectivesNicola Normanno, Alessandro Morabito, Antonella De Luca, et al.
Expert Review of Anticancer Therapy|March 5, 2016
A new look at the ALK gene in cancer: copy number gain and amplificationFederica Zito Marino, Gaetano Rocco, Alessandro Morabito, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2016
Crizotinib Response in a Late Relapse of ALK-positive Lung AdenocarcinomaFederica Zito Marino, Alessandro Morabito, Cesare Gridelli, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
World Journal of Gastroenterology|March 20, 2008
Is human hepatocellular carcinoma a hormone-responsive tumor?Massimo Di Maio, Bruno Daniele, Sandro Pignata, et al.
The Oncologist|December 7, 2007
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatmentAlessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, et al.
Nature Reviews. Clinical Oncology|January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Annals of the New York Academy of Sciences|January 31, 2007
Hormonal treatment of human hepatocellular carcinomaMassimo Di Maio, Ermelinda De Maio, Alessandro Morabito, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Endocrine-Related Cancer|June 16, 2009
Target-based therapies in breast cancer: current status and future perspectivesNicola Normanno, Alessandro Morabito, Antonella De Luca, et al.
Expert Review of Anticancer Therapy|March 5, 2016
A new look at the ALK gene in cancer: copy number gain and amplificationFederica Zito Marino, Gaetano Rocco, Alessandro Morabito, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 19, 2016
Crizotinib Response in a Late Relapse of ALK-positive Lung AdenocarcinomaFederica Zito Marino, Alessandro Morabito, Cesare Gridelli, et al.
The Oncologist|October 27, 2005
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancerGiampietro Gasparini, Domenico Gattuso, Alessandro Morabito, et al.
International Journal of Gastrointestinal Cancer|February 10, 2007
Multiorganic dissemination of a colorectal signet ring cell carcinoma with fulminant clinical courseRaffaele Longo, Alessandro Morabito, Guido Carillio, et al.
World Journal of Gastroenterology|March 20, 2008
Is human hepatocellular carcinoma a hormone-responsive tumor?Massimo Di Maio, Bruno Daniele, Sandro Pignata, et al.
The Oncologist|December 7, 2007
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatmentAlessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, et al.
Nature Reviews. Clinical Oncology|January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Pageof 20